An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) (ixCELL DCM)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Vericel Corporation
ClinicalTrials.gov Identifier:
NCT01670981
First received: August 20, 2012
Last updated: March 22, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2017
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)